Skip to main content

Rosa David J.'s Form 4 filing

Intuitive Surgical Inc (ISRG) · filed Mar 6, 2025

Accession no.
0001035267-25-000080
Filed
Mar 6, 2025
Trade date
Mar 5, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.20M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rosa David J.CIK 0001519593Director, Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 5, 2025Common StockMOption exerciseAcquired+14,625$77.00+$1,126,125233,807Direct
Mar 5, 2025Common StockSSaleDisposed−8,369$557.47F2−$4,665,466.43225,438Direct
Mar 5, 2025Common StockMOption exerciseAcquired+14,625$59.46+$869,602.5240,063Direct
Mar 5, 2025Common StockSSaleDisposed−8,140$557.58F3−$4,538,701.2231,923Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 5, 2025Common StockMOption exerciseDisposed−14,625$0.00$00Direct
Mar 5, 2025Common StockMOption exerciseDisposed−14,625$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,466 shares sold at $554.17 to $554.79; 2,122 shares sold at $556.44 to $557.39; 1,968 shares sold at $557.51 to $558.35; 2,663 shares sold at $558.58 to $559.38; 100 shares sold at $559.63; and 50 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,305 shares sold at $554.17 to $554.57; 1,751 shares sold at $556.44 to $557.42; 2,133 shares sold at $557.51 to $558.28; 2,748 shares sold at $558.52 to $559.37; 100 shares sold at $559.63; and 103 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)